Medsider Radio: Learn From Proven Medtech And Healthcare Experts

In this episode of Medsider Radio, we had an insightful discussion with Patrick Anquetil, CEO of Portal Instruments, a company developing a novel needle-free drug delivery system. This cutting-edge technology promises to revolutionize how medications are administered, making the process less invasive, more precise, and more comfortable for patients. Patrick brings over 20 years of experience leading bioengineering companies from concept to commercial success. Before Portal, he co-founded two medtech startups, SynapDx and Aretais. Patrick holds a doctorate in Mechanical Engineering from MIT, and advanced degrees from Harvard Business School, ETH Zurich, and the University of Tokyo. His scientific achievements have been featured in top journals and media outlets such as MIT Technology Review, Wired Magazine, PBS, and CNBC.In this interview, Patrick talks about how he landed on Portal’s business model, how their team condenses timelines across key company functions, and why their diverse set of partners is a gol

In this episode of Medsider Radio, we sat down with Tess Cosad, a femtech enthusiast and CEO of Béa Fertility. Béa offers effective, hormone-free, affordable, at-home fertility treatments and ovulation tracking as an alternative to traditional clinic-based offerings. Before Béa, Tess founded Emberson Ventures, a B2B marketing agency, and Hers By Design, a femtech company. She was also the first woman to lead a digital marketing-focused accelerator program in Saudi Arabia.In this interview, Tess delves into the challenges and triumphs of launching a consumer-facing product, the importance of a solid design team, how to be comfortable making decisions with imperfect information, and the lessons she learned about being a CEO while raising funds.Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Se

In this episode of Medsider Radio, we had an awesome chat with  Carla Spina, the pioneering force behind Noa Therapeutics. Carla and her team are developing treatments for inflammatory skin diseases with their innovative multimodal small-molecule therapies.Carla began her academic journey at the University of Calgary in the fields of inorganic and analytical chemistry, and continued with a Ph.D. in Bioinorganic Chemistry at McGill University. After going to BASF in Germany to develop pharmaceutical formulations, Carla returned to Canada and led the development and global commercialization of antimicrobial wound care devices. Later, she also pioneered first-in-class pharmaceuticals for inflammatory and infectious skin diseases. Currently, she spearheads Noa Therapeutics, a Canadian biotech firm that is transforming how immune diseases are treated.In this episode, Carla shares her invaluable experiences on the importance of engaging actively with the startup ecosystem and staying connected with those who are sh

In this episode of Medsider Radio, we had a fascinating discussion with Daniel Powel, CEO of Spark Biomedical, the company behind Sparrow Ascent, a drug-free wearable device to combat opioid withdrawal symptoms. It is also advancing neurostimulation technology to address Neonatal Opioid Withdrawal Syndrome. Daniel found his true passion in medical devices, specifically neurostimulation, in 2006 and has since launched multiple products in the space for companies like St. Jude Medical, LivaNova, and Getinge. He co-founded Spark Biomedical in 2018, which now has two FDA-cleared devices to treat opioid addiction.In this interview, Daniel shares key insights from his journey: the importance of testing ideas and creating a MVP, diversifying funding sources, and how to make informed regulatory decisions.Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head ove

In this episode of Medsider Radio, we had an enlightening conversation with Ken Mariash, a leading figure in the neuromodulation space and the CEO of Sinaptica Therapeutics, where his team is developing groundbreaking treatments for Alzheimer's disease. Their device delivers non-invasive neuromodulation therapy to key networks of the brain and has shown unprecedented improvement in treating this debilitating disease. Ken's two decades of experience leading sophisticated organizations has taken him from management consulting at Charles River Associates to significant roles at CSL, Baxter, and Boston Scientific. During his time at Boston, Ken was instrumental in commercialization and strategy development in the company’s $1B neuromodulation division. In this interview, Ken shares his time-tested wisdom, covering a range of topics from kick-starting a venture and how to approach M&A transactions, to mastering commercialization and best practices for engaging with investors.Before we dive into the discussion,

In this episode of Medsider Radio, we had an insightful conversation with Dave Rosa, President and CEO of NeuroOne, a company developing high-definition, minimally invasive neurology devices utilizing unique thin-film electrode technology. Dave brings over three decades of experience in the medical device industry. His career spans several key roles at major firms like C.R. Bard, Boston Scientific, and St. Jude Medical, focusing on marketing, product development, strategy, and commercialization. Dave has several medical device patents to his name, has served on numerous corporate boards, and raised over $200 million in the capital markets. He holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.In this interview, Dave discusses critical strategies to secure initial capital even before early development and regulatory milestones are achieved, how to leverage networks to connect with potential investors; and the importance of assembling a supportive and experienced t

In this episode of Medsider Radio, we sat down with John Bertrand, the CEO of Digital Diagnostics, a company that is pioneering AI healthcare systems. Its flagship product, LumineticsCore, is an algorithm that autonomously diagnoses patients with diabetic retinopathy. John's career started at Epic Systems, where he rapidly advanced through various roles, focusing on product and business development. His expertise in digital healthcare, honed at Epic, led to his role at 8VC, a Silicon Valley venture capital firm, where he concentrated on artificial intelligence in medical imaging. Eventually joining Digital Diagnostics as CEO, John combined his extensive industry experience with a passion for innovative healthcare technology solutions.In this interview, John shares his insights on aligning products with real-world needs, the importance of stakeholder engagement for adoption and long-term success, and strategies for navigating the extended sales cycles in healthcare technology. Before we dive into the discussio

In this episode of Medsider Radio, we had a fun discussion with Nick Delmonico, CEO of Strados Labs, the company developing a wearable stethoscope to remotely capture lung sounds.  Nick boasts a dynamic background with an MBA from the Fox School of Business at Temple University and a Bachelor's in Accounting from the University of Delaware. His career includes roles at ECG Management Consultants, PwC, and J.P. Morgan, where he honed his skills in healthcare strategy, commercialization and operations, business planning, and project management.In this interview, Nick talks about how Strados validated its technology through others' research and how starting with a clear understanding of the problem, rather than jumping straight to offering solutions, created significant opportunities for his company. He also emphasizes why interpersonal skills and active listening are crucial to success in medtech, and shares strategies for non-dilutive funding as a way to alleviate initial capital constraints while building cre

In this episode of Medsider Radio, we had a riveting conversation with Greg Bullington, co-founder and CEO of Magnolia Medical, who is leading a team in the development of Steripath, a revolutionary device that dramatically improves the accuracy of sepsis tests.Greg’s previous expertise includes leadership positions across biotech, healthcare access, and enterprise software. Over the last decade, Greg has shaped every facet of Magnolia's success, from creating their own category and navigating the regulatory landscape with FDA to collaborating with the U.S. Senate for the widespread adoption of Steripath.In this interview, Greg talks about the pivotal role of robust clinical data, why Magnolia is still running studies even after proving their device’s efficacy, and how to use the results to successfully convince different entities of its benefits, such as FDA and other government bodies in public health. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from m

In this episode of Medsider Radio, we had a spirited conversation with Sahil Diwan, CEO of SafKan Health. Sahil's company is developing the OtoSet, the first automated and FDA-cleared ear-cleaning device. With a background in computer science from the University of Oregon, Sahil's entrepreneurial journey began early. He was already coding at the age of 16 and building startups during his college years. Sahil’s venture into medical technology was inspired by his brother Aadil's struggle with impacted earwax.In this interview, we talk about consumer-driven medtech, the power of design, garnering experience from real-world data, focusing on building the business before fundraising, and how OtoSet went viral on social media. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to

In this episode of Medsider Radio, we had a riveting chat with David Hochman, founder and CEO of Orchestra BioMed, a company accelerating high-impact technologies through risk-reward-sharing partnerships with leading medical device companies.David has over two decades of experience in healthcare entrepreneurship, venture capital, and investment banking. He has a history of leading successful medical startups, including Orchestra Medical Ventures and Accelerated Technologies. As Chairman of Motus GI and former board member of Corbus Pharmaceuticals and PROLOR Biotech, David has been instrumental in advancing medical technologies, contributing to significant mergers & acquisitions, and many fundraising successes.In this interview he talks about driving successful partnerships, operational excellence in R&D, and the importance of a long-term strategy for sustainable industry innovation through aligned incentives. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into l

In this episode of Medsider Radio, we sat down with Deanne McCarthy, founder and CEO of Swiftsure Innovations, a company developing a device capable of safely and effectively cleaning the oral cavity of patients on life support. Deanne was a critical care nurse before she decided to make the switch to medtech entrepreneur. With Deanne's commitment to empowering nurses and enhancing patient outcomes, Swiftsure has assembled an adept team and a robust group of advisors that has enabled the company to move incredibly quickly across key functions like product development, regulatory affairs, and commercialization. In this interview, we explore the invaluable role of mentors and connections in Deanne's journey, her insights on accelerator programs, and how her initial lack of startup experience gave her the tenacity to seek out and validate collaborative partners.  Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders

In this episode of Medsider Radio, we sat down with Cecile Brosset Dubois, CEO of Sonio, a company dedicated to revolutionizing obstetric ultrasound through AI technology.  Cecile began her career in 2005 at Capgemini, later advancing to Bain & Company. Her strategic insights as Head of Strategy at FSI - Fonds Stratégique d'Investissement - and her pivotal roles at Bpifrance set the stage for Cecile's entrepreneurial journey. At Kamet Ventures, she fully embraced the startup world before eventually co-founding Sonio. In this interview, we touch on her strategic approach to product development, the importance of an in-house regulatory team, her drive for meaningful work, and effective tactics for fundraising. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behi

In this episode of Medsider Radio, we had a chat with Tyler Melton, the co-founder and CEO of Corveus Medical, a Houston-based startup on a mission to redefine heart failure treatment. Tyler previously worked at Accenture, consulting for top-tier pharmaceutical companies, and at the J&J Center for Device Innovation, where he honed his skills in strategic planning and financial modeling. He then joined the Texas Medical Center Biodesign Program, where he uncovered his current mission: to treat heart failure with targeted nerve ablation. In this interview, Tyler shares how using off-the-shelf products for early prototypes saved him both time and money and how accelerator programs provided the networking boost his startup needed to tackle the demanding PMA regulatory pathway. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com an

In this episode of Medsider Radio, we sat down with Angus McLachlan, CEO of Liberate Medical, a company pioneering a non-invasive neuromuscular electrical stimulator to prevent muscle weakening in patients who rely on a ventilator to breathe.Angus has a rich academic and professional history that intersects engineering and healthcare. Originating from Scotland, Angus began his academic journey in mechanical engineering at the University of Glasgow. This laid the foundation for his PhD research focused on electrical muscle stimulation for spinal cord injuries. His innovative work gained the attention of Apellis Pharma, leading to a collaboration that propelled the launch of his own company, Liberate Medical.  In this interview, we talk about Angus’s do-it-yourself philosophy, how a deep understanding of the technology you’re developing gives you leverage across multiple functions, and the nuances of pitching to investors. Before we dive into the discussion, I wanted to mention a few things:First, if you’re int

In this episode of Medsider Radio, we sat down with Kelly Roman, co-founder and CEO of Fisher Wallace, a company spearheading the development of wearable brain stimulation technology aimed at providing relief from depression, anxiety, and insomnia. Kelly is a Harvard graduate with an English major who took an unconventional path to medtech inspired by his experience co-authoring the graphic novel adaptation of Sun Tzu's "The Art of War." He took a career leap from literature and marketing to pioneer a novel approach to the treatment of mental health. In this interview, we delve into what Kelly's learned on his journey, touching on the value of unconventional thinking, the importance of making mental health treatments more accessible and less stigmatized, and the potential of decentralized clinical trials. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live,

In this episode of Medsider Radio, we had a chat with Dr. Alberto Rodriguez-Navarro, CEO of Levita Magnetics, a startup aiming to make surgical procedures as minimally invasive as possible with its advanced magnetic technology. Dr. Rodriguez-Navarro is not only a skilled surgeon but a medtech visionary with multiple patents to his name. Discover Alberto's journey spanning his childhood fascination with using magnets to clean the inside of his turtle tank to leveraging this concept into a cutting-edge magnetic surgery platform.  In this interview,  Dr. Rodriguez-Navarro discusses what to consider when starting a new business, how to hone your framework when transitioning from the clinic, and early-stage strategies to ease the road to FDA approval. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newslett

In this episode of Medsider Radio, we sat down with Bill Colone, the CEO and Chairman of SinglePass, a company developing an electrocautery device for deep tissue biopsies.Bill previously headed Spinal Singularity, raising over $11 million for product and clinical development. He was VP of R&D at Direct Flow Medical and the President of Endomed, which was sold in 2005. Bill also served in multiple leadership roles at Endologix and holds 13 U.S. patents with more pending. He earned his bachelor's in Chemical Engineering from Arizona State University, where he later served as an Associate Faculty Member and sits on the advisory committee for Chemical and Materials Engineering.In this interview, Bill shares invaluable insights and actionable strategies for building and leveraging an expansive network, optimizing fundraising, and strategically planning for both acquisition and independent growth. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical d

In this episode of Medsider Radio, we sat down with Shyam Natarajan, founder and CEO of Avenda Health, which utilizes artificial intelligence and cutting-edge imaging to improve the diagnosis and treatment of prostate cancer.After getting his PhD in Biomedical Engineering from UCLA, Shyam worked as a postdoctoral scholar in UCLA's Department of Surgery, focusing on minimally invasive surgical interventions. He also managed the UCLA Business of Science Center, spearheading initiatives to guide students toward non-academic career paths. With experiences like founding UCLA Innovation Week and the Inventathon, he is committed to pushing the boundaries of medical technology. At Avenda Health, Shyam is now leading the charge in revolutionizing prostate cancer care. In this interview, we talk about what it really takes to understand the market need for your product or service, how prototypes can be incredibly helpful in convincing relevant parties, how Shyam approaches fundraising, and what to expect from medtech in

In this episode of Medsider Radio, we sat down with Dr. David Albert, founder of AliveCor, which is pioneering the standard for personal ECG devices that extend beyond hardware and encompass services and partnerships to offer comprehensive personal cardiovascular solutions.Dr. Albert is a multifaceted individual — a physician, scientist, inventor, serial entrepreneur, YouTube sensation, and even an adventurous surfer. His academic journey led him from Duke University, where he completed both engineering and medical graduate studies, back to his roots at the University of Oklahoma. He already had several licensed inventions when he decided to stake it all on a new cardiovascular device. The gamble led him to found AliveCor, now a frontrunner in personal electrocardiograms (ECGs) under the renowned Kardia brand. In this interview, we take a tour down the lanes of innovation, prototyping, fundraising, and why sometimes you have to ditch the white coat to take your ideas from the lab to the real world.Before we d